WO2002015919A3 - Saratin for inhibiting platelet adhesion to collagen - Google Patents
Saratin for inhibiting platelet adhesion to collagen Download PDFInfo
- Publication number
- WO2002015919A3 WO2002015919A3 PCT/EP2001/009746 EP0109746W WO0215919A3 WO 2002015919 A3 WO2002015919 A3 WO 2002015919A3 EP 0109746 W EP0109746 W EP 0109746W WO 0215919 A3 WO0215919 A3 WO 0215919A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- saratin
- platelet adhesion
- collagen
- inhibiting platelet
- polypeptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
Abstract
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2419385A CA2419385C (en) | 2000-08-25 | 2001-08-23 | Saratin for inhibiting platelet adhesion to collagen |
US10/362,476 US6881722B2 (en) | 2000-08-25 | 2001-08-23 | Saratin for inhibiting platelet adhesion to collagen |
EP01976139A EP1311284B1 (en) | 2000-08-25 | 2001-08-23 | Saratin for inhibiting platelet adhesion to collagen |
SK313-2003A SK287829B6 (en) | 2000-08-25 | 2001-08-23 | Saratin for inhibiting platelet adhesion to collagen |
DE60107962T DE60107962T2 (en) | 2000-08-25 | 2001-08-23 | SARATIN FOR INHIBITING PLATZADHESIS ON COLLAGEN |
SI200130310T SI1311284T1 (en) | 2000-08-25 | 2001-08-23 | |
BR0113478-7A BR0113478A (en) | 2000-08-25 | 2001-08-23 | Specific mechanism for inhibition of platelet adhesion to collagen |
HU0303747A HU229367B1 (en) | 2000-08-25 | 2001-08-23 | Saratin for inhibiting platelet adhesion to collagen |
KR1020037002188A KR100794277B1 (en) | 2000-08-25 | 2001-08-23 | A new specific mechanism for inhibiting platelet adhesion to collagen |
UA2003032476A UA77402C2 (en) | 2000-08-25 | 2001-08-23 | Use of saratin for inhibition platelet adhesion |
PT01976139T PT1311284E (en) | 2000-08-25 | 2001-08-23 | A NEW SPECIFIC MECHANISM TO INHIBIT THE ADHESION OF PLATELETS TO COLLAGEN |
JP2002520840A JP4988131B2 (en) | 2000-08-25 | 2001-08-23 | A novel specific mechanism for inhibiting platelet adhesion to collagen |
DK01976139T DK1311284T3 (en) | 2000-08-25 | 2001-08-23 | A new specific mechanism for inhibiting platelet adhesion to collagen |
AU9550601A AU9550601A (en) | 2000-08-25 | 2001-08-23 | A new specific mechanism for inhibiting platelet adhesion to collagen |
AT01976139T ATE285246T1 (en) | 2000-08-25 | 2001-08-23 | SARATIN FOR INHIBITING PLATELE ADHESION ON COLLAGEN |
MXPA03001604A MXPA03001604A (en) | 2000-08-25 | 2001-08-23 | A new specific mechanism for inhibiting platelet adhesion to collagen. |
AU2001295506A AU2001295506B2 (en) | 2000-08-25 | 2001-08-23 | Saratin for inhibiting platelet adhesion to collagen |
NO20030841A NO331326B1 (en) | 2000-08-25 | 2003-02-24 | Use of saratin for the manufacture of a drug for inhibiting platelet adhesion to collagen |
HK04102595A HK1059736A1 (en) | 2000-08-25 | 2004-04-14 | A new specific mechanism for inhibiting platelet adhesion to collagen |
US11/016,854 US7459438B2 (en) | 2000-08-25 | 2004-12-21 | Specific mechanism for inhibiting platelet adhesion to collagen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00118542.0 | 2000-08-25 | ||
EP00118542 | 2000-08-25 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10362476 A-371-Of-International | 2001-08-23 | ||
US11/016,854 Division US7459438B2 (en) | 2000-08-25 | 2004-12-21 | Specific mechanism for inhibiting platelet adhesion to collagen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002015919A2 WO2002015919A2 (en) | 2002-02-28 |
WO2002015919A3 true WO2002015919A3 (en) | 2002-05-30 |
Family
ID=8169664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/009746 WO2002015919A2 (en) | 2000-08-25 | 2001-08-23 | Saratin for inhibiting platelet adhesion to collagen |
Country Status (27)
Country | Link |
---|---|
US (2) | US6881722B2 (en) |
EP (1) | EP1311284B1 (en) |
JP (1) | JP4988131B2 (en) |
KR (1) | KR100794277B1 (en) |
CN (1) | CN1224421C (en) |
AR (1) | AR030492A1 (en) |
AT (1) | ATE285246T1 (en) |
AU (2) | AU2001295506B2 (en) |
BR (1) | BR0113478A (en) |
CA (1) | CA2419385C (en) |
CZ (1) | CZ302353B6 (en) |
DE (1) | DE60107962T2 (en) |
DK (1) | DK1311284T3 (en) |
EC (1) | ECSP034485A (en) |
ES (1) | ES2234896T3 (en) |
HK (1) | HK1059736A1 (en) |
HU (1) | HU229367B1 (en) |
MX (1) | MXPA03001604A (en) |
MY (1) | MY128992A (en) |
NO (1) | NO331326B1 (en) |
PT (1) | PT1311284E (en) |
RU (1) | RU2302880C2 (en) |
SI (1) | SI1311284T1 (en) |
SK (1) | SK287829B6 (en) |
UA (1) | UA77402C2 (en) |
WO (1) | WO2002015919A2 (en) |
ZA (1) | ZA200302296B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7691839B2 (en) | 2005-09-28 | 2010-04-06 | Biovascular, Inc. | Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU767172B2 (en) * | 1999-03-18 | 2003-11-06 | Merck Patent Gmbh | Protein for blocking platelet adhesion |
AU2004204262B2 (en) | 2003-01-10 | 2010-11-04 | Ablynx N.V. | Recombinant VHH single domain antibody from camelidae against von willebrand factor (vWF) or against collagen |
US20110034396A1 (en) * | 2005-09-28 | 2011-02-10 | Biovascular, Inc. | Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions |
US20080069774A1 (en) * | 2005-11-17 | 2008-03-20 | Lance Liotta | Proteomic antisense molecular shield and targeting |
CN117229423B (en) * | 2023-11-10 | 2024-02-06 | 北京科技大学 | Polypeptide nano material for binding collagen and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992007005A1 (en) * | 1990-10-10 | 1992-04-30 | Merck Patent Gmbh | Platelet adhesion inhibitor |
US5246715A (en) * | 1988-06-24 | 1993-09-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same |
WO1995001375A1 (en) * | 1993-07-01 | 1995-01-12 | Merck Patent Gmbh | Inhibitor of collagen-stimulated platelet aggregation |
WO2000056885A1 (en) * | 1999-03-18 | 2000-09-28 | Merck Patent Gmbh | Protein for blocking platelet adhesion |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947401A (en) * | 1971-10-05 | 1976-03-30 | Union Optics Corporation | Hydrogels of unsaturated ester copolymers |
US5705355A (en) | 1984-03-27 | 1998-01-06 | Transgene, S.A. | Hirudin, pharmaceutical compositions comprising it and their use |
US4898734A (en) * | 1988-02-29 | 1990-02-06 | Massachusetts Institute Of Technology | Polymer composite for controlled release or membrane formation |
US5304121A (en) * | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
CA2052486A1 (en) * | 1990-10-09 | 1992-04-10 | Thomas M. Connolly | Protein for inhibiting collagen-stimulated platelet aggregation |
US5179082A (en) * | 1990-11-13 | 1993-01-12 | Merck & Co., Inc. | Method for blocking platelet adhesion to collagen |
DE4136513A1 (en) | 1991-11-06 | 1993-05-13 | Basf Ag | NEW THROMBIN INHIBITORIC PROTEIN FROM RUBBER BUGS |
PT711158E (en) * | 1993-07-29 | 2004-04-30 | Us Gov Health & Human Serv | METHOD FOR TREATING ATHEROSCLEROSIS OR RESTENING USING A MICROTUBLE STABILIZING AGENT |
US5532287A (en) * | 1994-05-04 | 1996-07-02 | Ciba-Geigy Corporation | Radiation cured drug release controlling membrane |
US6246715B1 (en) * | 1998-06-26 | 2001-06-12 | Samsung Electronics Co., Ltd. | Data transmitter and receiver of a DS-CDMA communication system |
US5843172A (en) * | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
WO2000023459A1 (en) * | 1998-10-16 | 2000-04-27 | Immunex Corporation | Inhibitors of platelet activation and recruitment |
IT1304135B1 (en) * | 1998-11-26 | 2001-03-07 | Magneti Marelli Spa | INJECTION AND IGNITION CONTROL METHOD IN A DIRECT INJECTION THERMAL ENGINE TO ACCELERATE THE HEATING OF THE |
ES2202061T3 (en) * | 1999-02-19 | 2004-04-01 | Zymogenetics, Inc. | INHIBITORS TO USE IN HEMOSTATIC AND IMMUNOLOGICAL FUNCTION. |
-
2001
- 2001-08-22 MY MYPI20013935A patent/MY128992A/en unknown
- 2001-08-23 SK SK313-2003A patent/SK287829B6/en not_active IP Right Cessation
- 2001-08-23 MX MXPA03001604A patent/MXPA03001604A/en active IP Right Grant
- 2001-08-23 CA CA2419385A patent/CA2419385C/en not_active Expired - Fee Related
- 2001-08-23 AU AU2001295506A patent/AU2001295506B2/en not_active Ceased
- 2001-08-23 HU HU0303747A patent/HU229367B1/en not_active IP Right Cessation
- 2001-08-23 RU RU2003107919/15A patent/RU2302880C2/en not_active IP Right Cessation
- 2001-08-23 AT AT01976139T patent/ATE285246T1/en active
- 2001-08-23 WO PCT/EP2001/009746 patent/WO2002015919A2/en active IP Right Grant
- 2001-08-23 EP EP01976139A patent/EP1311284B1/en not_active Expired - Lifetime
- 2001-08-23 UA UA2003032476A patent/UA77402C2/en unknown
- 2001-08-23 BR BR0113478-7A patent/BR0113478A/en not_active Application Discontinuation
- 2001-08-23 DE DE60107962T patent/DE60107962T2/en not_active Expired - Lifetime
- 2001-08-23 ES ES01976139T patent/ES2234896T3/en not_active Expired - Lifetime
- 2001-08-23 US US10/362,476 patent/US6881722B2/en not_active Expired - Fee Related
- 2001-08-23 CZ CZ20030720A patent/CZ302353B6/en not_active IP Right Cessation
- 2001-08-23 JP JP2002520840A patent/JP4988131B2/en not_active Expired - Fee Related
- 2001-08-23 DK DK01976139T patent/DK1311284T3/en active
- 2001-08-23 PT PT01976139T patent/PT1311284E/en unknown
- 2001-08-23 KR KR1020037002188A patent/KR100794277B1/en not_active IP Right Cessation
- 2001-08-23 SI SI200130310T patent/SI1311284T1/xx unknown
- 2001-08-23 AU AU9550601A patent/AU9550601A/en active Pending
- 2001-08-23 CN CNB018146600A patent/CN1224421C/en not_active Expired - Fee Related
- 2001-08-27 AR ARP010104073A patent/AR030492A1/en not_active Application Discontinuation
-
2003
- 2003-02-21 EC EC2003004485A patent/ECSP034485A/en unknown
- 2003-02-24 NO NO20030841A patent/NO331326B1/en not_active IP Right Cessation
- 2003-03-24 ZA ZA200302296A patent/ZA200302296B/en unknown
-
2004
- 2004-04-14 HK HK04102595A patent/HK1059736A1/en not_active IP Right Cessation
- 2004-12-21 US US11/016,854 patent/US7459438B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246715A (en) * | 1988-06-24 | 1993-09-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same |
WO1992007005A1 (en) * | 1990-10-10 | 1992-04-30 | Merck Patent Gmbh | Platelet adhesion inhibitor |
WO1995001375A1 (en) * | 1993-07-01 | 1995-01-12 | Merck Patent Gmbh | Inhibitor of collagen-stimulated platelet aggregation |
WO2000056885A1 (en) * | 1999-03-18 | 2000-09-28 | Merck Patent Gmbh | Protein for blocking platelet adhesion |
Non-Patent Citations (1)
Title |
---|
BARNES C S ET AL: "Production and characterization of saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion to collagen.", SEMINARS IN THROMBOSIS AND HEMOSTASIS, (2001 AUG) 27 (4) 337-48. REF: 54, XP001027785 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7691839B2 (en) | 2005-09-28 | 2010-04-06 | Biovascular, Inc. | Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
US8188034B2 (en) | 2005-09-28 | 2012-05-29 | Biovascular, Inc. | Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL162719A0 (en) | Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin andderivatives thereof | |
WO2003045523A3 (en) | Therapeutic coating for an intravascular implant | |
AU2002365875A1 (en) | Stent designed for the delivery of therapeautic substance or other agents | |
AU6158001A (en) | Drug/drug delivery systems for the prevention and treatment of vascular disease | |
AU2002225780A1 (en) | Coating with anti-microbial agent for refrigerator shelving | |
ZA979822B (en) | Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent. | |
BR0010659B1 (en) | Method for the manufacture of absorbent article having fastening feature with small self-adhesion. | |
WO2001085201A3 (en) | Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis | |
AU2002248319A1 (en) | Pharmaceutical composition for the prevention and treatment of scar tissue | |
WO2002015919A3 (en) | Saratin for inhibiting platelet adhesion to collagen | |
WO2000069255A8 (en) | Anti-inflammatory therapy for inflammatory mediated infection | |
AU2002330850A1 (en) | Use of inhibitors of the abc drug transporter to increase the activity of anti-microbial agents | |
EP0870502A3 (en) | Use of adenosine uptake inhibitors for the manufacture of a medicament for the treatment of pancreatitis | |
WO2002064160A8 (en) | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof | |
WO1998053850A3 (en) | Compositions and means for the treatment of burns and other cutaneous traumas | |
WO2002046225A3 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
WO2002022107A3 (en) | Pharmaceutical composition having modified carrier | |
AU2001244461A1 (en) | Venous line catheter and method of operating the same | |
HUP0001097A3 (en) | Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions | |
WO2002022074A3 (en) | Use of 2- and 4- quinolones for inhibiting intimal neo-proliferation | |
AU2001287560A1 (en) | Agent for inhibiting adhesion of the pathogenic flora of the skin | |
AR027958A1 (en) | COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES, INCLUDING PROPIONIL L-CARNITINE AND COENZYME Q10 | |
MY140504A (en) | Statin-mmp inhibitor combinations | |
WO2005014021A3 (en) | Use of zkw peptide for preparing an inhibitor drug against platelet aggregation | |
AU2002364734A1 (en) | Low pressure coated article having the appearance of stainless steel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 1200300282 Country of ref document: VN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001976139 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037002188 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/001604 Country of ref document: MX Ref document number: 2419385 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10362476 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001295506 Country of ref document: AU Ref document number: 018146600 Country of ref document: CN Ref document number: 2002520840 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2003-720 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3132003 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: 331/KOLNP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/02296 Country of ref document: ZA Ref document number: 200302296 Country of ref document: ZA |
|
ENP | Entry into the national phase |
Ref document number: 2003107919 Country of ref document: RU Kind code of ref document: A Ref country code: RU Ref document number: RU A |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037002188 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2001976139 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2003-720 Country of ref document: CZ |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001976139 Country of ref document: EP |